AKT1 and hepatocellular carcinoma: We examined four common PI3K mutations (which can highly activate the p-AKT pathway) in five HCC samples by the Sanger method of DNA sequencing, and did not detect any PI3K mutations in these samples (Supplementary Figure S1B).